Open AccessOptimization of 90 Y-antiCD20 preparation for radioimmunotherapy
Author(s) -
Amir Reza Jalilian,
Nazila Gholipour,
Ariandokht Vakili,
Edalat Radfar,
Ali BahramiSamani,
Simindokht ShirvaniArani,
Mohammad GhannadiMaragheh
Publication year - 2013
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.113350
Subject(s) - radioimmunotherapy , biodistribution , chemistry , specific activity , radiochemistry , conjugate , monoclonal antibody , antibody , medicine , immunology , biochemistry , in vitro , enzyme , mathematical analysis , mathematics
The advent of monoclonal antibodies such as Rituximab, in recent years, has brought about decisive progress in the treatment of aggressive and indolent non-Hodgkin's lymphoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom